106 related articles for article (PubMed ID: 2536643)
1. Chronic MK421 fails to modify evolution of hypertension in neonatally coarcted pups.
Bagby SP; Fuchs EF
Hypertension; 1989 Feb; 13(2):91-101. PubMed ID: 2536643
[TBL] [Abstract][Full Text] [Related]
2. Chronic CEI alters effect of low Na+ diet in normal and coarcted pups. I. BP, renin, and GFR.
Bagby SP; Fuchs E
Am J Physiol; 1989 Feb; 256(2 Pt 2):R523-30. PubMed ID: 2537042
[TBL] [Abstract][Full Text] [Related]
3. Chronic CEI alters effect of low Na+ diet in normal and coarcted pups. II. Na+ and H2O balance.
Bagby SP; Fuchs E
Am J Physiol; 1989 Feb; 256(2 Pt 2):R531-40. PubMed ID: 2537043
[TBL] [Abstract][Full Text] [Related]
4. Canine neonatally induced coarctation hypertension in the second year. Variably hyperresponsive plasma renin activity.
Bagby SP; Baur GM
Hypertension; 1983; 5(3):328-35. PubMed ID: 6341218
[TBL] [Abstract][Full Text] [Related]
5. Acute responses to arterial pressure and plasma renin activity to converting enzyme inhibition (SQ 20,881) in serially studied dogs with neonatally-induced coarctation hypertension.
Bagby SP
Hypertension; 1982; 4(1):146-54. PubMed ID: 6174444
[TBL] [Abstract][Full Text] [Related]
6. In vitro determinants of plasma renin activity in serially-studied inbred dogs with neonatally induced coarctation hypertension: renin reactivity, renin substrate, and renin concentration.
Bagby SP; McDonald WJ; Gray DK
Clin Exp Hypertens (1978); 1981; 3(3):455-75. PubMed ID: 7018860
[TBL] [Abstract][Full Text] [Related]
7. Abnormalities of renal perfusion and the renal pressor system in dogs with chronic aortic coarctation.
Bagby SP; McDonald WJ; Strong DW; Porter GA; Bennett WM; Bonchek LI
Circ Res; 1975 Nov; 37(5):615-20. PubMed ID: 1192558
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a vasodepressor effect of the angiotensin-converting enzyme inhibitor, MK421 (enalapril), independent of blockade of angiotensin II formation.
Wilkes BM
J Cardiovasc Pharmacol; 1984; 6(6):1036-42. PubMed ID: 6084759
[TBL] [Abstract][Full Text] [Related]
9. The effect of enalapril (MK421), an angiotensin converting enzyme inhibitor, on the conscious pregnant ewe and her foetus.
Broughton Pipkin F; Wallace CP
Br J Pharmacol; 1986 Mar; 87(3):533-42. PubMed ID: 3026539
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
[TBL] [Abstract][Full Text] [Related]
11. Extracellular volume expansion and delayed resolution of hypertension after canine aortic coarctectomy.
Wickre CG; Baur GM; Wong J; Woodruff J; Bagby SP
Life Sci; 1983 Mar; 32(11):1197-206. PubMed ID: 6339851
[TBL] [Abstract][Full Text] [Related]
12. Renal and systemic effects of enalapril in chronic one-kidney hypertension.
Woods RL; Anderson WP; Korner PI
Hypertension; 1986 Feb; 8(2):109-16. PubMed ID: 3002979
[TBL] [Abstract][Full Text] [Related]
13. Preventive effect of chronic converting enzyme inhibition on aortic stiffening induced by renovascular hypertension in conscious dogs.
Fischer EI; Levenson J; Barra JG; Armentano RL; Pichel RH; Simon A
Cardiovasc Res; 1993 Jun; 27(6):1039-44. PubMed ID: 8221761
[TBL] [Abstract][Full Text] [Related]
14. Enalapril (MK421) and its lysine analogue (MK521): a comparison of acute and chronic effects on blood pressure, renin-angiotensin system and sodium excretion in normal man.
Hodsman GP; Zabludowski JR; Zoccali C; Fraser R; Morton JJ; Murray GD; Robertson JI
Br J Clin Pharmacol; 1984 Mar; 17(3):233-41. PubMed ID: 6324833
[TBL] [Abstract][Full Text] [Related]
15. Converting-enzyme inhibitor enalapril (MK421) in treatment of hypertension with renal artery stenosis.
Hodsman GP; Brown JJ; Davies DL; Fraser R; Lever AF; Morton JJ; Murray GD; Robertson JI
Br Med J (Clin Res Ed); 1982 Dec; 285(6356):1697-9. PubMed ID: 6293638
[TBL] [Abstract][Full Text] [Related]
16. Enalapril in treatment of hypertension with renal artery stenosis. Changes in blood pressure, renin, angiotensin I and II, renal function, and body composition.
Hodsman GP; Brown JJ; Cumming AM; Davies DL; East BW; Lever AF; Morton JJ; Murray GD; Robertson JI
Am J Med; 1984 Aug; 77(2A):52-60. PubMed ID: 6089557
[TBL] [Abstract][Full Text] [Related]
17. Converting enzyme inhibitors and brain angiotensin.
Phillips MI; Kimura B
J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S82-90. PubMed ID: 2438497
[TBL] [Abstract][Full Text] [Related]
18. Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects.
MacGregor GA; Markandu ND; Bayliss J; Roulston JE; Squires M; Morton JJ
Br Med J (Clin Res Ed); 1981 Aug; 283(6288):401-3. PubMed ID: 6266576
[TBL] [Abstract][Full Text] [Related]
19. The persistent effect of long-term enalapril on pressure natriuresis in spontaneously hypertensive rats.
Dukacz SA; Adams MA; Kline RL
Am J Physiol; 1997 Jul; 273(1 Pt 2):F104-12. PubMed ID: 9249597
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of MK421, a new angiotensin converting enzyme inhibitor, in man.
Kasai Y; Abe K; Yasujima M; Tajima J; Seino M; Chiba S; Sato K; Goto T; Omata K; Tanno M
Tohoku J Exp Med; 1983 Dec; 141(4):417-22. PubMed ID: 6322384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
